MedPath

Efeect of Astaxanthin supplementation in women with Polycystic ovary syndrome (PCOs)

Not Applicable
Recruiting
Conditions
Polycystic Ovary Syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20231001059573N1
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
44
Inclusion Criteria

PCOS diagnosis according to Rotterdam 2003 criteria
Have a body mass index of 25-35 kg/m 2
Absence of pregnancy and breastfeeding
No intake of medicine
Not willing to get pregnant during the study

Exclusion Criteria

Ongoing pregnancy
Changing their usual diet or eating habits or level of physical activity
Presence of Skin or digestive allergy symptoms or any complications by intake of Astaxanthin supplementation
Smoking or alcohol consumption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath